graph Evidence gap map comparisons
KRAS gene alteration targeted therapyNTRK gene alteration targeted therapyRET gene alteration targeted therapy
sotorasib larotrectinib pralsetinib selpercatinib
Comparator:
Risk of bias:  low;   some concerns;   high;  NA;